...
首页> 外文期刊>American Journal of Veterinary Research >Orthotopic model of canine osteosarcoma in athymic rats for evaluation of stereotactic radiotherapy
【24h】

Orthotopic model of canine osteosarcoma in athymic rats for evaluation of stereotactic radiotherapy

机译:无胸腺大鼠犬骨肉瘤的原位模型用于立体定向放射治疗的评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective-To develop an orthotopic model of canine osteosarcoma in athymic rats as a model for evaluating the effects of stereotactic radiotherapy (SRT) on osteosarcoma cells. Animals-26 athymic nude rats. Procedures-3 experiments were performed. In the first 2 experiments, rats were injected with 1 x 10(6) Abrams canine osteosarcoma cells into the proximal aspect of the tibia (n = 12) or distal aspect of the femur (6). Tumor engraftment and progression were monitored weekly via radiography, luciferase imaging, and measurement of urine pyridinoline concentration for 5 weeks and histologic evaluation after euthanasia. In the third experiment, 8 rats underwent canine osteosarcoma cell injection into the distal aspect of the femur and SRT was administered to the affected area in three 12-Gy fractions delivered on consecutive days (total radiation dose, 36 Gy). Percentage tumor necrosis and urinary pyridinoline concentrations were used to assess local tumor control. The short-term effect of SRT on skin was also evaluated. Results-Tumors developed in 10 of 12 tibial sites and all 14 femoral sites. Administration of SRT to rats with femoral osteosarcoma was feasible and successful. Mean tumor necrosis of 95% was achieved histologically, and minimal adverse skin effects were observed. Conclusions and Clinical Relevance-The orthotopic model of canine osteosarcoma in rats developed in this study was suitable for evaluating the effects of local tumor control and can be used in future studies to evaluate optimization of SRT duration, dose, and fractionation schemes. The model could also allow evaluation of other treatments in combination with SRT, such as chemotherapy or bisphosphonate, radioprotectant, or parathyroid hormone treatment. (Am J Vet Res 2013;74:452-458)
机译:目的-建立无胸腺大鼠犬骨肉瘤的原位模型,作为评估立体定向放射疗法(SRT)对骨肉瘤细胞作用的模型。动物-26只无胸腺裸鼠。进行了3次实验。在前两个实验中,向大鼠的胫骨近端(n = 12)或股骨远端(6)注射了1 x 10(6)艾布拉姆斯犬骨肉瘤细胞。每周通过射线照相术,荧光素酶成像,安定性安乐死后的5周尿嘧啶啉浓度和组织学评估监测肿瘤的植入和进展。在第三个实验中,对8只大鼠的股骨远端进行了犬骨肉瘤细胞注射,并将SRT分三天(连续放射剂量,36 Gy)递送给患处。肿瘤坏死百分比和尿吡啶啉浓度用于评估局部肿瘤控制。还评估了SRT对皮肤的短期影响。结果:在12个胫骨部位中的10个以及全部14个股骨部位中发生了肿瘤。对股骨骨肉瘤大鼠施用SRT是可行和成功的。组织学上平均肿瘤坏死达到95%,并且观察到最小的不良皮肤影响。结论与临床意义-本研究建立的大鼠骨肉瘤原位模型适用于评估局部肿瘤控制的效果,可用于未来的研究中,以评估SRT持续时间,剂量和分级方案的优化。该模型还可以评估与SRT结合的其他治疗方法,例如化学疗法或双膦酸盐治疗,放射防护剂或甲状旁腺激素治疗。 (Am J Vet Res 2013; 74:452-458)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号